Search results for moderna
People

Filosofia Moderna
@FilosofiaMderna

Donna Moderna
@DonnaModerna

La Vida Moderna
@vidamoderna

Modern Agriculture Updates 
@ModernAgUpdates

Moderna de Pueblo
@ModernaDePueblo

Villa_am_Kaiserweg
@ModernArtLove

Moderna 
@moderna_tx

Madre Moderna ♔
@MadreModerna

Moderna
@Moderna

Modern Adult
@adultproblem

Modern ADU Plans
@ModernADUPlans

Modern Art Oxford
@mao_gallery

Mamá Moderna
@mama_moderna

Business Analyst Grp
@ModernAnalyst

ModernAgeVision
@ModernAgeVision

Modern Athlete
@modern_athlete

La Lengua Moderna
@lalenguamoderna

ModernArsenal
@ModernArsenal

modernart
@modern_art99

ModernaWoman: Vaccinated & Still Masked
@5M23129
Tweets including moderna
Pfizer $PFE buena subida ayer del 3,6% aprovechando el tirón de Moderna que subía más del 100% por los resultados de un ensayo de cáncer. Ahora llega la resistencia en 28,7$ 👀 Si la rompe tendríamos vía libre hacia los 32$ 🎯 pero no nos olvidemos de la MMA200 que viene bajando

@kazukabu88j Modernaって聞いて、久しぶりに聞いた!と思いましたもん。そもそもコロナで知った企業😅
El verdadero pata negra de los picacódigo.
Un Tesla de la era moderna.
Dennis Ritchie created C in the early 1970s without Google, Stack Overflow, GitHub, or any AI ( Claude, Cursor, Codex) assistant.
- No VC funding.
- No viral launch.
- No TED talk.
- Just two engineers at Bell Labs. A terminal. And a problem to solve.
He built a language that fit in kilobytes.
50 years later, it runs everything.
Linux kernel. Windows. macOS.
Every iPhone. Every Android.
NASA’s deep space probes.
The International Space Station.
> Python borrowed from it.
> Java borrowed from it.
> JavaScript borrowed from it.
If you have ever written a single line of code in any language, you did it in Dennis Ritchie’s shadow.
He died in 2011.
The same week as Steve Jobs.
Jobs got the front pages.
Ritchie got silence.
This Legend deserves to be celebrated.

A lot of gurus yesterday with Moderna $MRNA
I've been bullish on this for a while now...
I think this it's not done, but this was the easy trade. Probably now goes to ATH.

Nobody paying enough attention to $MRNA
100$ is the free money trade.
someone CTO this and send fees to a moderna or cancer charity
$MRNA
+177% sur la journée de bourse d'hier pour Moderna après avoir annoncé un vaccin contre un cancer cutané !

ఈ కంపెనీ స్టాక్ ఒక్క రోజులో 137 శాతం జంప్.. క్యాన్సర్ ట్రయల్ రిజల్ట్స్తో Modernaలో భారీ ర్యాలీ..!!
More Details: https://t.co/6QDfyXuM5c
#Moderna #ModernaStocks #StockDiaries #Goodreturnstelugu

MODERNA "INNATE PHARMA" le succès d'une phase III CONCERNE LA RÉCIDIVE APRÉS TRAITEMENT NOTAMMENT LA CHIRURGIE , ils n'ont pas sortis de chiffres comme le HR par exemple ! attention aux zygomars de tout poil qui voient un traitement global
📈 Cris-Tim crește profitul cu 33,9%, IMPACT pierde 87%, iar Electrica pregătește o finanțare de 8,7 mld. lei.
În SUA, Fed păstrează deschisă opțiunea majorării dobânzilor, Moderna a urcat aproximativ 177%, iar Marvell 9,85% după acordul cu Google.
Citește Trendul Zilei → https://t.co/NNeAaBEmDq

$MRNA Das ist schon eine ziemlich außergewöhnliche Entwicklung. Moderna ist gestern im S&P 500 um 177 % gestiegen und hat damit einen historischen Tagesanstieg hingelegt. Auslöser war die Meldung, dass die Phase-3-Studie des Unternehmens zu einem Impfstoff gegen Hautkrebs erfolgreich war. Wenn sich die Ergebnisse auch in der weiteren Entwicklung bestätigen, könnte das für Moderna medizinisch und wirtschaftlich ein wichtiger Wendepunkt sein. 🚀

@DrewPavlou Do you have any idea where the Moderna SP was prior to killing so many people with the dodgy Covid vaccine?
You fool!!
Whilst the Moderna news circulates - thought it was worth highlighting a trial from 2010 with Thymosin Alpha-1.
The peptide Thymosin Alpha-1 (Tα1) also enhances immune control of tumours.
It improves Th1 & NK cell responses to help detect & neutralise cancerous cells.
In a metastatic melanoma trial, adding Tα1 to dacarbazine ~tripled tumor responses (tumour shrinking) and extended median survival from 6.6 → 9.4 months vs control.

Imagina que te despiertas una mañana y es verano del año 2001. No existe la tecnología moderna. ¿Qué es lo primero que harías?
Moderna-Merck personalised cancer vaccine takes step closer to market after trial success, could be available next year https://t.co/xrTVxWhLgW
#Moderna is giving American turbo cancer with their mRNA vaccines, is now coming up with a cure, making trillions for years to come. Their stock went sky high. I’ll bet the Senators & the dudes in charge of FDA who knew this bought MRNA 🤷♂️🤷🏻♀️🤷🏻reaping 6 digit figures
Nothing says ‘trust the science’ like believing a $200+ billion-a-year cancer industry is eager to eliminate its own market.
https://t.co/WVOGphtoQT
モデルナとメルクが共同開発している
「オーダーメイド型のmRNAがんワクチン」の
臨床試験で
メラノーマ(皮膚がんの一種)の患者に対し
がんの再発や転移を防ぐ高い効果が確認された
感染症予防の一般的なワクチンとは異なり
「患者一人ひとりの腫瘍の遺伝子変異」に合わせて個別に作られるワクチン
Moderna i Merck conclouen amb "resultats positius" els assajos clínics d'una vacuna contra el càncer de pell | Ràdio Tàrrega https://t.co/39kPWhFzvE

「速報:FDAデータの再分析が Kennedy長官に送付され、Modernaの mRNAインフルエンザワクチンの承認は直ちに取り消されるべきと結論」
BREAKING: FDA DATA REANALYSIS SENT TO SECRETARY KENNEDY FINDS MODERNA’S mRNA FLU SHOT APPROVAL SHOULD BE IMMEDIATELY WITHDRAWN
We directly reanalyzed the FDA’s own data used to approve mFLUSIVA and found an EXTREME risk-benefit profile that is impossible to justify.
To prevent just ONE influenza hospitalization, 5,017 people had to be vaccinated at the COST of:
~2 excess unexplained DEATHS
~278 disabling Grade 3 systemic reactions
~3,798 adverse reactions
Compared with the standard-dose flu vaccine, that amounts to approximately 1,454 ADDITIONAL adverse reactions and 233 ADDITIONAL disabling Grade 3 systemic reactions for every hospitalization prevented.
Unexplained deaths were 2.55× more frequent among mFLUSIVA recipients, while disabling Grade 3 systemic reactions were 6.15× more frequent than with the standard-dose flu vaccine.
Literally EVERY SINGLE solicited adverse event was more frequent in the mFLUSIVA group.
Neither pivotal trial included a placebo arm, and no influenza-mortality endpoint was ever measured.
Moreover, mFLUSIVA commits recipients to annual lifelong exposure to nucleoside-modified mRNA technology despite evidence of residual DNA contamination, genomic integration, protein misfolding, proteostatic collapse, body-wide biodistribution, years-long persistence, and compounded biological injury with repeated dosing.
Our study and accompanying information were sent directly to Secretary Kennedy and officials at HHS, FDA, CDC, and NIH.
We hope Secretary Kennedy and federal health officials make the life-saving decision to remove this extremely hazardous product from the market before widespread administration begins. In light of the evidence now before them, allowing mFLUSIVA to remain approved would be a grave mistake.
The government has been given the data. It now has the responsibility to ACT.
@SecKennedy

Un contrato de opciones sobre Moderna ($MRNA) por noticias de vacunas explotó un 700.000% de un día para el otro: convirtió $1 en $7.000.
























